Provision Consulting GroupMay 2, 20223 minFDA NewsCounterfeit At-Home OTC COVID-19 Diagnostic TestsMay 02 2022 The FDA is aware of counterfeit at-home over-the-counter (OTC) COVID-19 diagnostic tests being distributed or used in the...
Provision Consulting GroupApr 29, 20222 minFDA NewsFDA approves new drug to improve heart function in adults with rare heart conditionApr 29 2022 FDA has approved Camzyos (mavacamten) capsules to treat adults with symptomatic New York Heart Association (NYHA)External...
Provision Consulting GroupApr 27, 20222 minFDA NewsFDA Approves First COVID-19 Treatment for Young ChildrenApr 27 2022 Today, the U.S. Food and Drug Administration expanded the approval of the COVID-19 treatment Veklury (remdesivir) to include...
Provision Consulting GroupApr 14, 20222 minFDA NewsFDA Authorizes First COVID-19 Diagnostic Test Using Breath SamplesApr 14 2022 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the first COVID-19 diagnostic...
Provision Consulting GroupApr 8, 20222 minFDA NewsFDA approves alpelisib for PIK3CA-related overgrowth spectrumApr 06 2022 On April 5, 2022, the Food and Drug Administration granted accelerated approval to alpelisib (Vijoice, Novartis...
Provision Consulting GroupApr 5, 20222 minFDA NewsFDA updates Sotrovimab emergency use authorizationApr 05 2022 Update [4/5/2022] Sotrovimab is no longer authorized to treat COVID-19 in any U.S. region due to increases in the proportion...